Solve enters litigation and competitive intelligence
Solve Intelligence
Charts matters because it moves Solve from helping lawyers write patents to helping them argue what those patents mean in fights over products, prior art, and standards. That shifts the company into a higher value workflow where teams upload large document sets, map claim elements to evidence, and use the output in litigation prep, licensing disputes, freedom to operate reviews, and competitor tracking, not just patent filing.
-
The workflow is much broader than prosecution. Solve says litigation teams can upload thousands of documents and generate infringement, invalidity, and freedom to operate charts, with each cell expandable to inspect reasoning and citations. That makes the product useful for outside counsel, in house IP teams, and licensing groups working from the same evidence base.
-
This also puts Solve closer to incumbent IP platforms and adjacent legal AI vendors. Clarivate bought Rowan TELS in July 2024 to add drafting and prosecution into its IP stack, while LexisNexis allied with Harvey in June 2025 to combine legal content with AI workflows. Solve is moving in the same direction from the opposite starting point, from niche patent workflow into broader legal analysis.
-
The expansion is landing while the company is scaling fast. Solve reached $12M ARR in December 2025, up from $1M a year earlier, served 400 plus IP teams, and raised a $40M Series B in December 2025. That gives it capital to sell a larger product bundle into the same customers instead of winning only drafting seats.
From here, the product is heading toward a full patent workbench, where drafting, prosecution, charting, and eventually life sciences specific tools sit in one system. If Solve keeps adding adjacent workflows, it can capture more of the budget that now gets split across drafting tools, patent databases, and litigation support software.